Si Bone Company Leadership

SIBN Stock  USD 12.65  0.09  0.72%   
Si Bone's insiders are aggressively selling. The analysis of insiders' sentiment of trading Si Bone stock suggests that virtually all insiders are panicking at this time. Si Bone employs about 344 people. The company is managed by 13 executives with a total tenure of roughly 36 years, averaging almost 2.0 years of service per executive, having 26.46 employees per reported executive.
Carlton Reckling  President
Chief Medical Officer and Vice President Medical Affairs
Scott Yerby  President
Vice President CTO

Si Bone's Insider Buying Vs Selling

0

 
Selling
 
Buying

Latest Trades

2024-11-18Anshul MaheshwariDisposed 2439 @ 12.68View
2024-11-04Jeffrey W DunnDisposed 341 @ 13.55View
2024-10-02Anthony J RecuperoDisposed 3305 @ 13.58View
2024-09-03Anshul MaheshwariDisposed 1414 @ 16.35View
2024-08-19Anthony J RecuperoDisposed 2087 @ 14.17View
2024-08-16Jeffrey W DunnDisposed 1580 @ 13.84View
2024-08-02Jeffrey W DunnDisposed 343 @ 14.32View
2024-07-02Anthony J RecuperoDisposed 3309 @ 12.92View
2024-06-10Jeffrey W DunnDisposed 341 @ 12.99View
2024-05-16Jeffrey W DunnDisposed 1581 @ 15.13View
2024-05-02Jeffrey W DunnDisposed 343 @ 14.54View
2024-04-02Anshul MaheshwariDisposed 2425 @ 15.45View
Monitoring Si Bone's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Si Bone. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
To learn how to invest in SIBN Stock, please use our How to Invest in Si Bone guide.

Si Bone's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Si Bone's future performance. Based on our forecasts, it is anticipated that SIBN will maintain a workforce of about 340 employees by December 2024.
 
Covid

Si Bone Management Team Effectiveness

The company has return on total asset (ROA) of (0.1154) % which means that it has lost $0.1154 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2209) %, meaning that it created substantial loss on money invested by shareholders. Si Bone's management efficiency ratios could be used to measure how well Si Bone manages its routine affairs as well as how well it operates its assets and liabilities. As of the 26th of November 2024, Return On Tangible Assets is likely to drop to -0.2. In addition to that, Return On Capital Employed is likely to drop to -0.24. At this time, Si Bone's Asset Turnover is very stable compared to the past year.
As of the 26th of November 2024, Common Stock Shares Outstanding is likely to drop to about 22.4 M. In addition to that, Net Loss is likely to drop to about (57.9 M)

Si Bone Workforce Comparison

Si Bone is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 23,959. Si Bone claims roughly 344 in number of employees contributing just under 2% to equities under Health Care industry.

Si Bone Profit Margins

The company has Profit Margin (PM) of (0.24) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.19) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.19.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.970.7878
Fairly Up
Pretty Stable

Si Bone Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Si Bone insiders, such as employees or executives, is commonly permitted as long as it does not rely on Si Bone's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Si Bone insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-09-01
0.1053
2
19
 20,201 
 29,252 
2024-06-01
0.625
10
16
 148,521 
 86,036 
2024-03-01
0.2692
7
26
 358,435 
 98,487 
2023-12-01
0.0667
1
15
 20,000 
 61,517 
2023-09-01
0.1111
3
27
 40,000 
 140,553 
2023-06-01
0.3846
10
26
 317,421 
 711,227 
2023-03-01
0.2353
8
34
 385,223 
 120,084 
2022-06-01
0.4
8
20
 58,368 
 24,147 
2022-03-01
0.6111
11
18
 334,103 
 25,070 
2021-09-01
0.0625
1
16
 13,635 
 33,836 
2021-06-01
0.4565
21
46
 217,828 
 477,607 
2021-03-01
0.3889
14
36
 294,295 
 1,155,608 
2020-12-01
0.05
1
20
 3,000 
 405,595 
2020-09-01
0.303
10
33
 53,543 
 263,402 
2020-06-01
0.6471
11
17
 74,550 
 68,854 
2020-03-01
0.5833
14
24
 350,632 
 1,084,547 
2019-12-01
0.2778
10
36
 52,190 
 133,576 
2019-09-01
0.2264
12
53
 42,018 
 1,369,303 
2019-06-01
0.4762
20
42
 166,167 
 140,976 
2018-12-01
0.5075
34
67
 14,738,086 
 13,050,182 

Si Bone Notable Stakeholders

A Si Bone stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Si Bone often face trade-offs trying to please all of them. Si Bone's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Si Bone's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Carlton RecklingChief Medical Officer and Vice President Medical AffairsProfile
Scott YerbyVice President CTOProfile
Saqib IqbalDirector RelationsProfile
Anshul MaheshwariChief OfficerProfile
Aimee EinsteinVice CultureProfile
Daniel CherSenior AffairsProfile
Michael PisetskyGeneral Counsel and Chief Compliance OfficerProfile
Laura MBACEO DirectorProfile
Nikolas KerrStrategy ProductProfile
Jeff BertoliniSenior TechnologyProfile
Michael JDSecretary OfficerProfile
Joseph PowersVP MarketingProfile
Anthony RecuperoChief Commercial OfficerProfile

About Si Bone Management Performance

The success or failure of an entity such as Si Bone often depends on how effective the management is. Si Bone management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of SIBN management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the SIBN management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.19)(0.20)
Return On Capital Employed(0.23)(0.24)
Return On Assets(0.19)(0.20)
Return On Equity(0.26)(0.27)

Si Bone Workforce Analysis

Traditionally, organizations such as Si Bone use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Si Bone within its industry.

Si Bone Manpower Efficiency

Return on Si Bone Manpower

Revenue Per Employee403.7K
Revenue Per Executive10.7M
Net Loss Per Employee126K
Net Loss Per Executive3.3M
Working Capital Per Employee546.3K
Working Capital Per Executive14.5M
When determining whether Si Bone offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Si Bone's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Si Bone Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Si Bone Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Si Bone. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
To learn how to invest in SIBN Stock, please use our How to Invest in Si Bone guide.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Si Bone. If investors know SIBN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Si Bone listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.92)
Revenue Per Share
3.817
Quarterly Revenue Growth
0.186
Return On Assets
(0.12)
Return On Equity
(0.22)
The market value of Si Bone is measured differently than its book value, which is the value of SIBN that is recorded on the company's balance sheet. Investors also form their own opinion of Si Bone's value that differs from its market value or its book value, called intrinsic value, which is Si Bone's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Si Bone's market value can be influenced by many factors that don't directly affect Si Bone's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Si Bone's value and its price as these two are different measures arrived at by different means. Investors typically determine if Si Bone is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Si Bone's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.